Tango Therapeutics Inc is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
TNGX is expected to report earnings to rise 9.86% to -31 cents per share on May 13
Q1'26
Est.
$-0.32
Q4'25
Beat
by $0.03
Q3'25
Missed
by $0.07
Q2'25
Est.
$-0.35
Q1'25
Est.
$-0.36
The last earnings report on March 05 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 54.45K shares outstanding, the current market capitalization sits at 1.50B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TNGX showed earnings on March 05, 2026. You can read more about the earnings report here.